1st EUGLOH Symposium on Nanomedicines

On 28 June, academics from the five members of the EUGLOH Alliance joined forces to offer a first EUGLOH-wide symposium on nanomedicines. The symposium was initiated by Prof. Elias Fattal, a Pharmaceutical Technology professor, former director of the Paris-Saclay Galien Institute, currently Vice-Dean in Charge of Research at the UPSaclay Faculty of Pharmacy and member of the steering committee of the HeadS Graduate School. Prof. Elias Fattal has longstanding collaborations with several researchers from the member universities of EUGLOH, with whom he has namely published several papers.

As a keen follower of EUGLOH since its creation, when Prof. Fattal mentioned the project of a symposium dedicated to nanomedicines, his counterparts were immediately on board. As Prof. Elias Fattal said: “Existing collaborations with several researchers from EUGLOH partners made the organisation of the symposium self-evident.” Thanks to the strong support of Simona Mura, Associate Professor at the Institut Galien Paris-Saclay, and that of senior lecturers Dorine Bonte and Eric Morel, from the Faculty of Pharmacy, who are heavily involved in EUGLOH, the symposium was able to come to life in just a few months.

The idea of this first symposium – with more to be organised subsequently – was to showcase what has been accomplished within the five EUGLOH partners in the field of nanomedicines. In the course of the day, exclusively held online, two plenary sessions were led by eminent researchers in the field, Prof. Patrick Couvreur, from Université Paris-Saclay, who spoke on Squalene-based nanocarriers for the delivery of small molecules, and Prof. Ernst Wagner, LMU Munich, who led a talk entitled RNA gene medicines: evolution of synthetic carriers. These were completed by a series of shorter 20-minute presentations and four roundtables.

Feedback from the audience was very positive. With 200 registered and over 150 participants connected at a given time, the symposium brought together a broad range of students, from undergraduates to PhDs, as well as senior scientists and postdoctoral fellows. Furthermore, the symposium did not only spark interest among EUGLOH audiences but also from countries around the globe, such as Brazil, India, Vietnam, Taiwan and Canada, and from institutions such as the French agency for the safety of health products, ANSM (Agence nationale de sécurité du medicament et des produits de santé).

More information on EUGLOH: https://www.universite-paris-saclay.fr/en/collaborations/international/eugloh-alliance-european-universities

More information on EUGLOH events: https://www.eugloh.eu/study-and-mobility/events